🇺🇸 FDA
Patent

US 8846051

Modulation of replicative fitness by deoptimization of synonymous codons

granted A61KA61K2039/522A61K2039/5254

Quick answer

US patent 8846051 (Modulation of replicative fitness by deoptimization of synonymous codons) held by The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
Grant date
Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K2039/522, A61K2039/5254, A61K39/00, A61K39/0258